Scientific Advisory Board

Guillermo Umpierrez, MD

Dr. Umpierrez is professor of medicine in the division of endocrinology at Emory University School of Medicine, Director of the Grady Memorial Hospital Clinical Research Network, Atlanta-CTSA, and Director of the Diabetes & Endocrinology Section at Grady Memorial Hospital, Atlanta, Georgia.

He is the recipient of numerous awards, including the American Association of Clinical Endocrinologists (AACE) Outstanding Service Award for the Promotion of Endocrine Health of an Underserved Population, the American Diabetes Association 2013 Outstanding Physician Clinician in Diabetes Award, and the 2013-2014 Best Grand Rounds Lecture Award, Department of Medicine at Emory University. He is a member of the National Board of Directors for the American Diabetes Association and the American Association of Clinical Endocrinologists, as well as a member of the Endocrine Society Clinical Guideline Committee and American Association of Clinical Endocrinologists Diabetes Scientific Council.

His research interests include mechanisms for beta-cell dysfunction in minority populations and the management of inpatient hyperglycemia. He is a national and international leader in the field of hospital management of diabetes and has published several landmark papers and guidelines in the field of inpatient diabetes. He heads the Emory Diabetes Council and the nationally-accredited Emory Latino Diabetes Education Program.

Dr. Umpierrez is Editor-in-Chief of the American Diabetes Association Therapy for Diabetes Mellitus and Related Disorders, 6th Edition Textbook (Green Book), and Editor-in-Chief of BMJ Open Diabetes Research & Care  (ADA and BMJ Collaborative project). He has published more than 300 scientific manuscripts and book chapters, and has presented more than 240 research abstracts at national and international scientific meetings.

Bruce Bode, MD

Dr. Bode is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia, and is currently on the faculty of Emory University, as a Clinical Associate Professor in the Department of Medicine.

He received his medical degree from Emory University School of Medicine and completed an internship and residency in internal medicine at Emory University Affiliated Hospitals and a fellowship in diabetes with Paul C. Davidson, MD.

He has a strong affinity for working with children and young adults with diabetes and is considered one of the leading experts in the world on insulin delivery and glucose sensing. He is very active in clinical research on new diabetes products including pharmacological agents to prevent diabetes and control glucose and new insulins and glucose sensors.

He is a prolific writer with over 200 articles and books in the field of diabetes discussing current and future therapies for people with diabetes. He also sits on the advisory board of many of the leading companies in the field of diabetes care and research including the Juvenile Diabetes Research Foundation, the American Diabetes Association (ADA), and the Georgia diabetes camps.

Steven V. Edelman, MD

Dr. Edelman is a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California at San Diego (UCSD) and the Veterans Affairs (VA) Healthcare System of San Diego and the director of the Diabetes Care Clinic, VA Medical Center. He achieved high honors during his undergraduate studies at the University of California at Los Angeles and was the valedictorian of his medical school class at the University of California Davis Medical School. He is board certified in internal medicine and metabolism, diabetes, and endocrinology. Dr. Edelman received his internal medicine training at the University of California Los Angeles, and completed his clinical endocrinology fellowship training at the Joslin and Lahey Clinics in Boston, Mass. as well as a research fellowship at UCSD.

Diagnosed with diabetes at the age of 15, Dr. Edelman has become a local and national leader in diabetes treatment, research and education. Dr. Edelman has strong interests in education and patient advocacy. He is the founder and director of Taking Control of Your Diabetes (TCOYD), a national not-for-profit organization with the goal of teaching and motivating patients in diabetes self-care.

Dr. Edelman has written more than 225 articles and five books. He is the Editor of the journals Insulin and Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. He has won numerous awards for teaching and humanitarianism and was recognized by San Diego Magazine as a Top Doctor eight of the last ten years. He was chosen as the teacher of the year amongst the over 500 faculty members at UCSD numerous times. He was awarded the Diabetes Educator of the year by the American Diabetes Association in 2009, the Distinction in Endocrinology award by the American Association of Clinical Endocrinologists in 2011, and recently named in US News and World Report amongst the top 1% of endocrinologists in the US.

Jay Fleischman, MD

Dr. Fleischman is Clinical Associate Professor of Ophthalmology at Albert Einstein College of Medicine. He was a systems analyst/programmer at New York’s NASA Goddard Institute for Space Studies while he completed his applied math/computer engineering and then medical degrees at Columbia University. He completed his ophthalmology training at the Wilmer Institute, Johns Hopkins and his retina specialty training at the Medical College of Wisconsin. In 1980, Dr. Fleischman became the Director of Retina at the Bethesda Eye Institute, St. Louis University and then served as Director at Montefiore Hospital, Albert Einstein College of Medicine to New York in 1988.

Since 1984, Dr. Fleischman has lectured and taught surgery around the world through Project ORBIS (the Flying Eye Hospital), has authored many papers, and holds patents, one pending on a device that will help restore vision to patients with macular degeneration, the leading cause of vision loss after age 55. Of the many surgical devices Dr. Fleischman has invented, the laser endophotocoagulator has become an indispensable tool and a worldwide “standard of care” for advanced surgical retina cases. An expert in diabetes treatment and its complications, in particular diabetic retinopathy, he served as an investigator in The Diabetes Control and Complications Trial (DCCT), a landmark medical study conducted by the US National Institute of Diabetes and Digestive and Kidney Diseases.

Dr. Fleischman has consulted for many companies including HGM, Alcon and Mentor and served as an advisor for Dauphin Capital Management and NGN Capital Management. As a Pfizer medical advisor at their Hospital Products Division he helped them evaluate many innovative medical devices and surgical instruments which served to increase the 1998 sale value of that division. He now serves as an FDA medical device panel member.

H. Courtenay Harrison Jr., MD

Dr. Harrison serves as Diabetes Center Medical Director at Sentara Virginia Beach General Hospital (SVBGH), a 282-bed, acute care, community hospital. Sentara Health System, listed in Modern HealthCare Magazine as the nation’s leading integrated health care system in 2011, has relied heavily on its clinicians to develop protocols, guidelines, and order sets. Dr. Harrison has served in various leadership roles throughout his career on the medical staff at SVBGH and has played a significant part in the development of diabetes order sets within Sentara’s eCare (EPIC) electronic record system. He has over twenty years of experience using the Glucommander software tool for IV insulin infusion at SVBGH to help manage inpatients with diabetes and hyperglycemia, and he has passionately supported this technology within the Sentara Health System, including a recent roll-out of Glucommander SubQ.

Dr. Harrison obtained his undergraduate and medical school education at the University of Virginia. He completed his internal medicine residency at Vanderbilt University, and a 3-year fellowship in Metabolism, Nutrition, and Endocrinology at the University of Washington in Seattle. He lives and practices in Virginia Beach, VA, as the senior member of Endocrinology Consultants, an eight-member endocrinology division of Bayview Medical Group in Hampton Roads, Virginia. Dr. Harrison is an Assistant Professor of Clinical Medicine at Eastern Virginia Medical School in Norfolk, VA and also joins a few of his colleagues for a once-a-month evening endocrine-diabetes clinic at the Virginia Beach Free Clinic.

Mikhail Kosiborod, MD

Dr. Kosiborod is a cardiologist and a clinical scholar at St. Luke's Mid America Heart Institute, and professor of medicine at the University of Missouri-Kansas City. Dr. Kosiborod received training in clinical epidemiology, health services research and health policy through the Robert Wood Johnson Clinical Scholars Program, as well as clinical training in cardiovascular medicine at Yale University School of Medicine.

Dr. Kosiborod's main research interests include diabetes and glucose control in patients with acute coronary syndromes. He has authored and co-authored many peer-reviewed publications and abstracts on this topic, including several scientific statements/position documents on in-hospital and long-term glucose control. He is a recipient of the American Heart Association Career Development Award in Implementation Research, which is focused on addressing knowledge gaps in our current understanding of the relationship between glucose control and outcomes in patients with acute myocardial infraction, and subsequently on improving the quality of care in this patient group.

Dr. Kosiborod is actively involved in the work of multiple committees for the American College of Cardiology and American Heart Association, currently chairs the Diabetes Committee of the American Heart Association, and is the training director for the Post-graduate Fellowship in Outcomes Research at Saint Luke’s Mid America Heart Institute.

Kendall Rogers, MD

Dr. Rogers is Chair of the Division of Hospital Medicine at the University of New Mexico and Associate Professor of Internal Medicine. He is board certified in Internal Medicine and attended medical school at the University Of New Mexico School Of Medicine. He is a Senior Fellow in the Society of Hospital Medicine (SHM) and Chair of their Information Technology Task Force. Dr. Rogers is the Glycemic Control Lead Mentor for the SHM and was co-author of Improving Outcomes with Clinical Decision Support: An Implementer's Guide, Second Edition that was named the 2012 HIMSS Book of the Year. The award honors a book that offers outstanding practical guidance and/or strategic insight for healthcare information and management systems professionals.

Amy Tenderich

Amy Tenderich is a journalist, blogger, and patient advocate who started after her diagnosis with type 1 diabetes in 2003. Her site has become a leading online destination for people with diabetes and one of the top health blogs around the country and the world. In 2006, she won the LillyforLife Achievement Award for diabetes journalism from the Eli Lilly & Company. She is the co-author, along with Dr. Richard Jackson of the Joslin Diabetes Center, of Know Your Numbers, Outlive Your Diabetes – a unique motivational guide to the 5 key medical tests that everyone with diabetes should have and monitor regularly.

Amy has made it her personal mission to spur innovation in diabetes care that actually originates with patients. She penned an Open Letter to Steve Jobs in 2007 that went viral, developing into an international crowdsourcing competition called the DiabetesMine Design Challenge. The competition was underwritten by the California HealthCare Foundation, and supported by IDEO, a leading design firm with close ties to Stanford University. The competition culminated in the DiabetesMine Innovation Summit, a unique annual gathering of diabetes stakeholders held at Stanford.

Amy was also instrumental in launching, the fastest-growing and most successful social networking site for people with diabetes. From January 2011 to May 2013, she served as Vice President of Patient Advocacy at DiabeticConnect’s parent company, Alliance Health Networks, which owns and operates over 50 social networking communities for people living with chronic conditions.

Request Demo